Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Understand the key factors that contribute to a successful small business idea. Leverage these insights to enhance your venture.
21,685 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
As factories re-shore production in 2026, three ETFs track the trend with different tilts. Here is how AIRR, PAVE, an...
The White House is proposing a 63% cut to the CDFI Fund for FY2027, raising questions about accountability vs. capaci...
Per Stirling Capital Management increased its stake in the First Trust Smith Opportunistic Fixed Income ETF (FIXD) by...
Bitcoin trades around $78,000 as PI token declines for a second straight weekend, fading hopes for a rebound. Analyst...
A new bloc within the GOP is breaking with Trump on key issues, forming the so-called YOLO caucus. The rise of anti-t...
As inflation and market volatility shape retirement outcomes, a prudent plan can stretch a $920,000 nest egg. The key...
The iShares Global Energy ETF IXC surged roughly half a year, but income investors now face a payout reckoning as oil...
Markets paused their march higher at midday as tech leadership shines and geopolitical headwinds test appetite. Marve...
A 56-year-old hospital administrator faces a potential half-million-dollar federal tax bill on an inherited $1.8 mill...
When tragedy hits, money becomes a quiet but crucial part of the story. This piece looks at forgiveness in a fatal cr...
JetBlue sparked attention by boosting its Q2 unit-revenue outlook, lifting airline sentiment and offering clues for t...